Effect of Internet-Based Pharmaceutical Care Path Management Model on Medication Adherence and Disease Control in Patients with Asthma-Chronic Obstructive Pulmonary Overlap Syndrome
Objective To investigate the effect of Internet-based pharmaceutical care path management model on medication adherence and disease control in patients with asthma-chronic obstructive pulmonary overlap syndrome(ACOS).Methods A total of 500 patients with ACOS admitted to the outpatient department of the hospital from May 2021 to May 2023 were selected and divided into the routine group(230 cases,implementation of the routine pharmaceutical care management plan in the outpatient department from May 2021 to April 2022)and the path management group(270 cases,implementation of the Internet-based pharmaceutical care path management model in the outpatient department from May 2022 to May 2023)according to the intervention mode.Both groups were managed for six months.Results The incidence of adverse reactions in the pathway management group was 9.26%,which was significantly lower than 20.00%in the routine group(P<0.05).The 8-items Morisky Medication Adherence Scale(MMAS-8),Antibiotics Use Density(AUD),number of drug varieties,clinical effective control rate[modified Medical Research Council(mMRC),COPD assessment test(CAT)],length of hospital stay,average monthly drug costs,and average monthly total hospitalization costs in the pathway management group were significantly lower than those in the routine group(P<0.05),while the Brief Medication Questionnaire(BMQ)and Asthma Control Test(ACT)scores in the pathway management group were significantly higher than those in the routine group(P<0.05).The satisfaction rate of pharmaceutical care in the pathway management group was 82.22%,which was significantly higher than 65.22%in the routine group(P<0.05).Conclusion The Internet-based pharmaceutical care path management model can significantly improve the medication adherence and satisfaction with pharmaceutical care in patients with ACOS,promote rational drug use,enhance the sense of medication belief,effectively control the disease,reduce clinical medication and hospitalization costs,and it has good safety.
Internetpharmaceutical care path management modelasthma-chronic obstructive pulmonary overlap syndromemedication adherencedisease control
万方数据
维普
